Galmed Pharmaceuticals Ltd. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 05/15/2023 | 1.35 M | $574,818 | -22.53% | 80.21% |
| MORGAN STANLEY | 05/15/2023 | 204,245 | $87,110 | 13.01% | 12.16% |
| RAYMOND JAMES & ASSOCIATES | 04/14/2023 | 138,040 | $58,874 | 0.00% | 8.22% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2023 | 131,628 | $56,000 | -11.79% | 7.83% |
| CITADEL ADVISORS LLC | 05/15/2023 | 40,844 | $17,420 | 100.00% | 2.43% |
| VIRTU FINANCIAL LLC | 05/01/2023 | 31,633 | $13,000 | 100.00% | 1.88% |
| WESTERN WEALTH MANAGEMENT, LLC | 08/30/2023 | 29,537 | $12,597 | 0.00% | 1.76% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 05/11/2023 | 28,500 | $12,000 | 0.00% | 1.70% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 04/14/2023 | 27,900 | $11,899 | 0.00% | 1.66% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2023 | 27,177 | $11,590 | 0.00% | 1.62% |
| BELPOINTE ASSET MANAGEMENT LLC | 05/15/2023 | 14,050 | $5,992 | 0.00% | 0.84% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2023 | 13,716 | $5,850 | 2,186.00% | 0.82% |
| JANE STREET GROUP, LLC | 05/16/2023 | 13,189 | $5,625 | -51.55% | 0.79% |
| UBS GROUP AG | 05/12/2023 | 4,307 | $1,835 | -79.90% | 0.26% |
| WELLS FARGO & COMPANY/MN | 05/12/2023 | 3,050 | $1,301 | 0.00% | 0.18% |
| TSFG, LLC | 04/21/2023 | 3,000 | $1,000 | 0.00% | 0.18% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 08/15/2024 | 2,500 | $1,068 | 0.00% | 0.15% |
| BOURGEON CAPITAL MANAGEMENT LLC | 04/17/2023 | 500 | $214 | 0.00% | 0.03% |
| ALLWORTH FINANCIAL LP | 04/18/2023 | 250 | $107 | 100.00% | 0.01% |
| ZRC WEALTH MANAGEMENT, LLC | 05/04/2023 | 100 | $43,000 | 100.00% | 0.01% |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 05/15/2023 | 10 | $4 | 100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 05/15/2023 | 0 | $0 | 0.00% | 0.00% |
| BENJAMIN F. EDWARDS & COMPANY, INC. | 04/27/2023 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/16/2023 | 0 | $0 | -100.00% | 0.00% |
| GROUND SWELL CAPITAL, LLC | 05/08/2023 | 0 | $0 | -100.00% | 0.00% |
| ACCURATE WEALTH MANAGEMENT, LLC | 04/13/2023 | 0 | $0 | -100.00% | 0.00% |
| TD WATERHOUSE CANADA INC. | 11/13/2023 | 0 | $0 | -100.00% | 0.00% |
Galmed Pharmaceuticals Ltd.institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Galmed Pharmaceuticals Ltd.. The most heavily invested institutionals were:
Advisor Group, Inc.: 0
Delek Group, Ltd.: 24,552
Unterberg Capital LLC: 0
GLG LLC: 0
Virtu KCG Holdings LLC: 0
Edmond de Rothschild (Europe): 916
122.72% of Galmed Pharmaceuticals Ltd. stock is owned by institutional investors.
Institutional investors have bought a total of 25,468 shares in the last 24 months. This purchase volume represents approximately $77,423 in transactions.